Suchergebnisse - "9NDF7JZ4M3"

PubPharm (4.971)

11

Anticoagulation for Patients With Concomitant Atrial Fibrillation and End-Stage Renal Disease : A Systematic Review and Network Meta-Analysis

enthalten in: Journal of the American Heart Association | 2024

von Kao, T. | Chen, Z. | Lin, Y.

12

The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors : An ANNEXA-4 Subanalysis

enthalten in: Circulation | 2024

von Siegal, D. | Forbes, N. | Eikelboom, J. | +5

13

Therapy adherence, safety and efficacy of rivaroxaban in prevention of venous thromboembolism in patients with hip or knee endoprosthesis

enthalten in: European journal of orthopaedic surgery & traumatology : orthopedie traumatologie | 2024

von Tomić, N. | Anđić, V. | Ćurlik, D. | +5

14

Common P-glycoprotein (ABCB1) polymorphisms do not seem to be associated with the risk of rivaroxaban-related bleeding events : Preliminary data

enthalten in: Biochemia medica | 2024

von Slišković, A. | Palić, J. | Božina, T. | +5

15

Exploring the effects of Factor Xa inhibitors on thrombin generation in people with haemophilia

enthalten in: Thrombosis research | 2024

von Dix, C. | McFadyen, J. | Tran, H.

16

Potential treatment option of rivaroxaban for breastfeeding women : A case series

enthalten in: Thrombosis research | 2024

von Yamashita, Y. | Hira, D. | Morita, M. | +11

17

Intrinsic coagulant potential modulates anticoagulant efficacy of rivaroxaban

enthalten in: Thrombosis research | 2024

von Pereira Portela, C. | Stirnimann, G. | Kröll, D. | +5

18

Patterns of atrial fibrillation anticoagulation with rivaroxaban - 7-year follow-up from the Dresden NOAC registry

enthalten in: Thrombosis research | 2024

von Tittl, L. | Marten, S. | Naue, C. | +1

19

Comparative effectiveness of factor Xa non-vitamin K antagonist oral anticoagulants versus phenprocoumon in patients with non-valvular atrial fibrillation

enthalten in: International journal of cardiology | 2024

von Kreutz, R. | Kloss, S. | Enders, D. | +4

20

Impact of very low dose rivaroxaban in addition to dual antiplatelet therapy on endogenous fibrinolysis in acute coronary syndrome : The VaLiDate-R study

enthalten in: Thrombosis research | 2024

von Gue, Y. | Memtsas, V. | Kanji, R. | +7